AtriCure (NSDQ:ATRC) shares gained today after the medical device company yesterday reported higher-than-expected sales and raised its outlook for the rest of the year. The Mason, Ohio-based cardiovascular device company posted losses of -$6.9 million, or -21¢ per share, on sales of $45.2 million for the three months ended June 30, paring its losses by -16.1% […]
AtriCure Inc.
Lumicell taps ex-Accuray COO Londy as CEO | Personnel Moves July 18, 2017
Lumicell said last week it tapped former Accuray (NSDQ:ARAY) chief operating officer Kelly Londy as its new chief exec, with founder W. Lee moving to take the role of prez & chief scientific officer. Prior to holding the COO position at Accuray, Londy has held leadership positions at GE Healthcare (NYSE:GE) and Royal Philips (NYSE:PHG), Lumicell said. “We are […]
AtriCure’s Q1 numbers top estimates
AtriCure (NSDQ:ATRC) beat the consensus forecast at both the top and bottom lines with its 1st-quarter results, sending share prices up 3% today. Losses for the Mason, Ohio-based medical device company rose4.7% to -$10.2 million, or -32¢ per share, on sales growth of 14.8% for the 3 months ended March 31. Analysts on Wall Street were looking […]
AtriCure gains on Q4
AtriCure (NSDQ:ATRC) shares are up today after the company beat the forecast with its 4th-quarter and full-year bottom line. The Mason, Ohio-based company pared its losses by -21.0% to -$8.6 million, or -27¢ per share, on sales of $41.2 million for the 3 months ended Dec. 31, for a top-line gain of 14.8% compared with Q4 […]
AtriCure warns on tip detachment risk with Cobra Fusion cardiac ablation device
AtriCure (NSDQ:ATRC) in September warned doctors of the risk that the tip of its Cobra Fusion cardiac ablation catheter could dislodge and separate from the device. The Cobra Fusion device is designed to deliver both bipolar and monopolar energy to the ablation site. The device also uses suction to gently pulls tissue out of the path of circulating blood […]
AtriCure shares dip despite Street-beating Q2
AtriCure (NSDQ:ATRC) released 2nd quarter earnings late yesterday that topped the street in losses per share, but still saw shares dip in trading today. The Mason, Ohio-based company reported losses of $8.2 million, or 26¢ per share, on sales of $39.7 million for the 3 months ended June 30. That amounts to a 67.8% increase in […]
AtriCure wins CE Mark for AtriClip Pro2 LAA occluder
AtriCure (NSDQ:ATRC) said today it won CE Mark approval in the European Union for the AtriClip Pro2 left atrial appendage exclusion system designed for minimally-invasive LAA occlusion procedures. The AtriClip Pro2 system is designed with an ambidextrous locking and trigger-style clip closing mechanism, the West Chester, Ohio-based company said, as well as handle-based active articulation levers […]
AtriCure launches cryoanalgesia study
AtriCure (NSDQ:ATRC) said today it launched and enrolled the 1st patient in the Frost trial which aims to examine the use of its CryoIce system designed for the cryoablation of peripheral nerves for the temporary management of post-operative pain. The trial is slated to enroll up to 100 patients to explore the use of cryoanalgesia in addition […]
AtriCure preps $150m offering
AtriCure (NSDQ:ATRC) registered for a securities offering worth $150 million that could bring in another $115 million for some of its stockholders in a secondary offering. West Chester, Ohio-based AtriCure said its portion of the flotation could include common stock, preferred stock, debt securities, warrants or depositary shares and units. The company won’t get any proceeds from the secondary offering […]
AtriCure wins FDA 510(k) for AtriClip Pro2 LAA device
AtriCure (NSDQ:ATRC) said today it won 510(k) clearance for its AtriClip Pro2 left atrial appendage exclusion system designed to occlude the LAA during minimally-invasive surgical procedures. The AtriClip Pro2 system is designed with an ambidextrous locking and trigger-style clip closing mechanism, the West Chester, Ohio-based company said, as well as handle-based active articulation levers and a […]
FDA clears AtriCure’s CryoForm cryoablation probe
AtriCure (NSDQ:ATRC) said yesterday it won FDA 510(k) clearance for its CryoForm cryoablation probe designed for use in cardiac ablation procedures, such as atrial fibrillation. The CryoForm is designed with the ability to remove heat and actively defrost, which allows the operator to safely detach the device while maintaining internal tissue’s frozen state, the West Chester, Ohio-based […]
